- Home
- HEPS vs GRAL Comparison
HEPS vs GRAL Comparison
Compare HEPS & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPS
- GRAL
- Stock Information
- Founded
- HEPS 2000
- GRAL 2016
- Country
- HEPS Turkey
- GRAL United States
- Employees
- HEPS N/A
- GRAL N/A
- Industry
- HEPS Catalog/Specialty Distribution
- GRAL
- Sector
- HEPS Consumer Discretionary
- GRAL
- Exchange
- HEPS Nasdaq
- GRAL NYSE
- Market Cap
- HEPS 811.7M
- GRAL 877.1M
- IPO Year
- HEPS 2021
- GRAL N/A
- Fundamental
- Price
- HEPS $2.66
- GRAL $38.41
- Analyst Decision
- HEPS
- GRAL Buy
- Analyst Count
- HEPS 0
- GRAL 3
- Target Price
- HEPS N/A
- GRAL $31.50
- AVG Volume (30 Days)
- HEPS 348.8K
- GRAL 1.6M
- Earning Date
- HEPS 06-12-2025
- GRAL 05-13-2025
- Dividend Yield
- HEPS N/A
- GRAL N/A
- EPS Growth
- HEPS N/A
- GRAL N/A
- EPS
- HEPS N/A
- GRAL N/A
- Revenue
- HEPS $1,471,066,066.00
- GRAL $130,711,000.00
- Revenue This Year
- HEPS $22.80
- GRAL $19.98
- Revenue Next Year
- HEPS $25.49
- GRAL $17.52
- P/E Ratio
- HEPS N/A
- GRAL N/A
- Revenue Growth
- HEPS 42.87
- GRAL 30.47
- 52 Week Low
- HEPS $1.71
- GRAL $12.33
- 52 Week High
- HEPS $4.05
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- HEPS 45.42
- GRAL N/A
- Support Level
- HEPS $2.56
- GRAL N/A
- Resistance Level
- HEPS $2.90
- GRAL N/A
- Average True Range (ATR)
- HEPS 0.11
- GRAL 0.00
- MACD
- HEPS 0.00
- GRAL 0.00
- Stochastic Oscillator
- HEPS 29.85
- GRAL 0.00
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.